- Home
- KZIA vs GRNQ Comparison
KZIA vs GRNQ Comparison
Compare KZIA & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- GRNQ
- Stock Information
- Founded
- KZIA 1994
- GRNQ 2013
- Country
- KZIA Australia
- GRNQ Malaysia
- Employees
- KZIA N/A
- GRNQ N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- GRNQ EDP Services
- Sector
- KZIA Health Care
- GRNQ Technology
- Exchange
- KZIA Nasdaq
- GRNQ Nasdaq
- Market Cap
- KZIA 5.1M
- GRNQ 12.8M
- IPO Year
- KZIA 1999
- GRNQ 2018
- Fundamental
- Price
- KZIA $10.77
- GRNQ $2.12
- Analyst Decision
- KZIA Strong Buy
- GRNQ
- Analyst Count
- KZIA 2
- GRNQ 0
- Target Price
- KZIA $14.00
- GRNQ N/A
- AVG Volume (30 Days)
- KZIA 692.0K
- GRNQ 84.5K
- Earning Date
- KZIA 07-22-2025
- GRNQ 08-12-2025
- Dividend Yield
- KZIA N/A
- GRNQ N/A
- EPS Growth
- KZIA N/A
- GRNQ N/A
- EPS
- KZIA N/A
- GRNQ N/A
- Revenue
- KZIA $1,549,158.00
- GRNQ $3,190,761.00
- Revenue This Year
- KZIA N/A
- GRNQ N/A
- Revenue Next Year
- KZIA N/A
- GRNQ N/A
- P/E Ratio
- KZIA N/A
- GRNQ N/A
- Revenue Growth
- KZIA 248983.08
- GRNQ N/A
- 52 Week Low
- KZIA $2.86
- GRNQ $0.80
- 52 Week High
- KZIA $40.75
- GRNQ $2.50
- Technical
- Relative Strength Index (RSI)
- KZIA 75.96
- GRNQ 65.90
- Support Level
- KZIA $5.86
- GRNQ $1.78
- Resistance Level
- KZIA $12.00
- GRNQ $2.50
- Average True Range (ATR)
- KZIA 1.03
- GRNQ 0.18
- MACD
- KZIA 0.41
- GRNQ 0.04
- Stochastic Oscillator
- KZIA 90.23
- GRNQ 63.11
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About GRNQ Greenpro Capital Corp.
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.